Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice
Tóm tắt
Từ khóa
Tài liệu tham khảo
Auewarakul, P., U. Kositanont, P. Sornsathapornkul, P. Tothong, R. Kanyok, and P. Thongcharoen. 2007. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine25:659-663.
Babiuk, S., D. M. Skowronski, G. De Serres, K. HayGlass, R. C. Brunham, and L. Babiuk. 2004. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model. J. Med. Virol.72:138-142.
Belshe, R. B., F. K. Newman, K. Wilkins, I. L. Graham, E. Babusis, M. Ewell, and S. E. Frey. 2007. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine25:6755-6763.
Birchall, J., S. Coulman, M. Pearton, C. Allender, K. Brain, A. Anstey, C. Gateley, N. Wilke, and A. Morrissey. 2005. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J. Drug Target.13:415-421.
Bresson, J. L., C. Perronne, O. Launay, C. Gerdil, M. Saville, J. Wood, K. Hoschler, and M. C. Zambon. 2006. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet367:1657-1664.
Chang, L. Y., S. R. Shih, P. L. Shao, D. T. Huang, and L. M. Huang. 2009. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J. Formos. Med. Assoc.108:526-532.
Claas, E. C., A. D. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet351:472-477.
Cubas, R., S. Zhang, S. Kwon, E. M. Sevick-Muraca, M. Li, C. Chen, and Q. Yao. 2009. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J. Immunother.32:118-128.
Desheva, J. A., X. H. Lu, A. R. Rekstin, L. G. Rudenko, D. E. Swayne, N. J. Cox, J. M. Katz, and A. I. Klimov. 2006. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential Vaccine24:6859-6866.
Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol.158:2278-2284.
Flacher, V., M. Bouschbacher, E. Verronese, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. Dezutter-Dambuyant, S. Lebecque, and J. Valladeau. 2006. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol.177:7959-7967.
Galarza, J. M., T. Latham, and A. Cupo. 2005. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol.18:244-251.
Gill, H. S., and M. R. Prausnitz. 2007. Coated microneedles for transdermal delivery. J. Control Release117:227-237.
Haynes, J. R., L. Dokken, J. A. Wiley, A. G. Cawthon, J. Bigger, A. G. Harmsen, and C. Richardson. 2009. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine27:530-541.
Holland, D., R. Booy, F. De Looze, P. Eizenberg, J. McDonald, J. Karrasch, M. McKeirnan, H. Salem, G. Mills, J. Reid, F. Weber, and M. Saville. 2008. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J. Infect. Dis.198:650-658.
Hon, H., and J. Jacob. 2004. Tracking dendritic cells in vivo: insights into DC biology and function. Immunol. Res.29:69-80.
Hung, C. F., B. Ma, A. Monie, S. W. Tsen, and T. C. Wu. 2008. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin. Biol. Ther.8:421-439.
Kang, S. M., D. G. Yoo, A. S. Lipatov, J. M. Song, C. T. Davis, F. S. Quan, L. M. Chen, R. O. Donis, and R. W. Compans. 2009. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One4:e4667.
Kenney, R. T., S. A. Frech, L. R. Muenz, C. P. Villar, and G. M. Glenn. 2004. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med.351:2295-2301.
Kim, Y. C., F. S. Quan, R. W. Compans, S. M. Kang, and M. R. Prausnitz. 2010. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J. Control Release142:187-195.
Kim, Y. C., F. S. Quan, D. G. Yoo, R. W. Compans, S. M. Kang, and M. R. Prausnitz. 2010. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J. Infect. Dis.201:190-198.
Koutsonanos, D. G., M. del Pilar Martin, V. G. Zarnitsyn, S. P. Sullivan, R. W. Compans, M. R. Prausnitz, and I. Skountzou. 2009. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One4:e4773.
Lin, J., J. Zhang, X. Dong, H. Fang, J. Chen, N. Su, Q. Gao, Z. Zhang, Y. Liu, Z. Wang, M. Yang, R. Sun, C. Li, S. Lin, M. Ji, Y. Liu, X. Wang, J. Wood, Z. Feng, Y. Wang, and W. Yin. 2006. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet368:991-997.
Lu, X., L. E. Edwards, J. A. Desheva, D. C. Nguyen, A. Rekstin, I. Stephenson, K. Szretter, N. J. Cox, L. G. Rudenko, A. Klimov, and J. M. Katz. 2006. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine24:6588-6593.
Ng, K. W., M. Pearton, S. Coulman, A. Anstey, C. Gateley, A. Morrissey, C. Allender, and J. Birchall. 2009. Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine27:5948-5955.
Nicholson, K. G., A. E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma, and M. C. Zambon. 2001. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet357:1937-1943.
Nicolas, J. F., and B. Guy. 2008. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev. Vaccines7:1201-1214.
Normile, D. 2006. Avian influenza. Human transmission but no pandemic in Indonesia. Science312:1855.
Pearton, M., C. Allender, K. Brain, A. Anstey, C. Gateley, N. Wilke, A. Morrissey, and J. Birchall. 2008. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm. Res.25:407-416.
Quan, F. S., Y. C. Kim, D. G. Yoo, R. W. Compans, M. R. Prausnitz, and S. M. Kang. 2009. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One4:e7152.
Ross, T. M., K. Mahmood, C. J. Crevar, K. Schneider-Ohrum, P. M. Heaton, and R. A. Bright. 2009. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One4:e6032.
Sailaja, G., I. Skountzou, F. S. Quan, R. W. Compans, and S. M. Kang. 2007. Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology362:331-341.
Skountzou, I., F. S. Quan, J. Jacob, R. W. Compans, and S. M. Kang. 2006. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine24:6110-6119.
Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology305:192-200.
Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science279:393-396.
Subbarao, K., B. R. Murphy, and A. S. Fauci. 2006. Development of effective vaccines against pandemic influenza. Immunity24:5-9.
Takada, A., S. Matsushita, A. Ninomiya, Y. Kawaoka, and H. Kida. 2003. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine21:3212-3218.
Tao, P., M. Luo, D. Zhu, S. Qu, Z. Yang, M. Gao, D. Guo, and Z. Pan. 2009. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral Immunol.22:273-281.
Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, C. B. Bridges, N. J. Cox, and K. Fukuda. 2004. Influenza-associated hospitalizations in the United States. JAMA292:1333-1340.
Tran, T. H., T. L. Nguyen, T. D. Nguyen, T. S. Luong, P. M. Pham, V. C. Nguyen, T. S. Pham, C. D. Vo, T. Q. Le, T. T. Ngo, B. K. Dao, P. P. Le, T. T. Nguyen, T. L. Hoang, V. T. Cao, T. G. Le, D. T. Nguyen, H. N. Le, K. T. Nguyen, H. S. Le, V. T. Le, D. Christiane, T. T. Tran, J. de Menno, C. Schultsz, P. Cheng, W. Lim, P. Horby, and J. Farrar. 2004. Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med.350:1179-1188.
Treanor, J. J., B. E. Wilkinson, F. Masseoud, J. Hu-Primmer, R. Battaglia, D. O'Brien, M. Wolff, G. Rabinovich, W. Blackwelder, and J. M. Katz. 2001. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine19:1732-1737.
Ungchusak, K., P. Auewarakul, S. F. Dowell, R. Kitphati, W. Auwanit, P. Puthavathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N. J. Cox, S. R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J. M. Simmerman, and S. Chunsutthiwat. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med.352:333-340.
Van Damme, P., F. Oosterhuis-Kafeja, M. Van der Wielen, Y. Almagor, O. Sharon, and Y. Levin. 2009. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine27:454-459.
Zhang, S., R. Cubas, M. Li, C. Chen, and Q. Yao. 2009. Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells. Mol. Immunol.46:1988-2001.